Scientists have revealed how mango plants activate a powerful antioxidant system to shield themselves from harmful ultraviolet-B (UV-B) rays. This cutting-edge discovery could pave the way for stronger, more resilient tropical crops in the future.

Shares of Atossa jumped 10% before regular trading hours, tied to the announcement of Orphan Drug Designation. This special status, granted to products for rare diseases, often provides key competitive benefits and regulatory incentives.

Scientists have recreated ancient enzymes that once helped cannabis produce multiple cannabinoids simultaneously. Their work reveals how today’s specialized THC, CBD, and CBC pathways originated from more robust, multitasking enzyme systems millions of years ago.

A father-son team from South Africa has reclaimed the Guinness World Record for the fastest quadcopter drone. Their Peregreen V4, a 3D-printed marvel, soared to an astonishing 408 mph, showcasing the incredible potential of cutting-edge drone technology.

A major trade show in Las Vegas underscores the growing prominence of robots and artificial intelligence in modern technology. Industry experts highlight the new wave of automation, prompting observers to echo a simple mandate: “Make way for the robots.”

Boston Dynamics unveiled its remarkable Atlas humanoid robot at CES 2026 in Las Vegas, showcasing years of refinement. With dexterity that continues to advance and AI innovations playing a key role, Atlas seems poised to tackle workplace tasks sooner rather than later.

XRlabs is developing a cutting-edge platform using NVIDIA Jetson Thor and NVIDIA Isaac to modernize surgical scopes. Through real-time AI analysis, vision-based tool tracking, and intent-aware automation, this initiative promises to optimize operating room workflows and improve clinical outcomes.

Nvidia is determined to integrate AI into the real world with new models unveiled at CES 2026. The company introduced Cosmos Reason 2, an updated vision-language model for embodied reasoning, alongside an expanded Nemotron family that aims to supercharge robotic intelligence.

Europol warns that crime involving humanoid robots could become widespread by 2035, fueled by the public’s growing unease. A new report suggests that without thoughtful intervention, hostility toward robots may escalate into widespread violence.

Around 450 squirrel-sized marmosets at Texas Biomed’s primate center in San Antonio are helping researchers unlock the mysteries of aging, health span, and longevity. Their unexpected sweet tooth for marshmallows adds a lighthearted twist to a serious scientific endeavor.

A new study introduces an innovative, soft deployable airless wheel designed to facilitate exploration of the Moon’s lava tubes. Published in the December 2025 issue of Science Robotics, this work brings forward a novel approach to space travel and technology.

If you’re craving a unique holiday spectacle, look no further than a mesmerizing hour-long video of a humanoid robot sorting packages. The clip, shared by Figure AI’s founder Brett Adcock, highlights the robot’s promise as a game-changer for future warehouse operations.

Researchers are using advanced sensors and artificial intelligence to make prosthetic hands feel more natural. Amputees who once felt disconnected from their bionic limbs could soon gain a closer connection, thanks to new innovations in this field.

Construction of AstraZeneca’s new plant in Albemarle County is progressing swiftly. Local officials have been briefed on both the expected salaries for newly hired workers and the overall size of the operations, raising anticipation about the region’s economic benefit.

Scientists have unveiled a bionic hand that uses AI to assist amputees with everyday tasks. By integrating proximity and pressure sensors into a commercial prosthesis, they have enabled more intuitive movement. This approach aims to redefine how individuals with limb loss interact with their environment.

Imviva Biotech has revealed promising new data for its allogeneic CAR-T cell therapies, CTD402 and CTA311, at the 67th American Society of Hematology Annual Meeting. Early clinical findings suggest significant progress toward treating T-cell and B-cell malignancies, as well as severe aplastic anemia, through innovative approaches that may offer enhanced efficacy and widened patient access.

Sana Biotechnology has announced the successful use of fusogen technology to deliver potent in vivo gene editing of human hematopoietic stem cells (HSCs). Published in Nature Biotechnology, the preclinical research highlights systemic delivery in murine models, demonstrating promising precision for bone marrow–based therapies.

Nanjing Leads Biolabs Co., Ltd. presented new clinical data on LBL-034 at the 67th Annual Meeting of the American Society of Hematology (ASH) in Orlando. The results, featuring a median progression-free survival (PFS) trending beyond one year, spotlight a potential breakthrough in hematology.

BioAge Labs, Inc. has released interim results showing that its novel brain-penetrant NLRP3 inhibitor, BGE-102, was well-tolerated in early testing. Preliminary data suggests this once-daily oral medication could bring new options for conditions linked to inflammatory pathways.

AstraZeneca has unveiled a $2 billion plan to expand its manufacturing presence in Maryland, a move that marks its fourth U.S. commitment this year. The announcement highlights not only the company’s continued growth but also the broader impact such investments can have on America’s biotech landscape.

AI is poised to transform Mars missions with enhanced autonomy, safety measures, and deeper scientific insights. As the technology evolves, it stands to redefine the way humanity explores and sustains its presence on the Red Planet.